Skip to main navigation
Lion Biotechnologies
  • About
    • About Iovance Biotherapeutics
    • Management Team
    • Board of Directors
    • Research Partners
  • Our Technology
    • About TIL
    • Application of TIL
    • Publication and Scientific Presentations
  • Clinical
    • Clinical Program
    • Clinical Pipeline
    • Unmet Medical Need
    • Metastatic Melanoma
    • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    • Cervical Carcinoma
    • Non Small Cell Lung Cancer (NSCLC)
  • Investors
    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Ownership Summary
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Financial Reports
      • Quarterly Results
      • Earnings Estimates
    • Fundamentals
      • Snapshot
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Ratios
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Corporate Profile
      • Information Request
      • E-mail Alerts
      • IR Contacts
  • Careers
    • Why Iovance?
    • Current Job Openings
  • Patients
  • News
  • Contact

About Lion Biotech

Home Investors Financial Reports

Financial Reports

Financial Reports

Thumbnail Documents
2019 annual report iovance
  • Add Files
    2019 Annual Report 12 MB
annualreport2018
  • Add Files
    2018 Annual Report 7 MB
2017AnnualReport1.jpg
  • Add Files
    2017 Annual Report 23.1 MB
  • Add Files
    2016 Annual Report 4.4 MB
  • Investor Toolkit
  • Print Page
  • RSS
  • E-mail Alerts
  • Home
    • hidden
  • About
  • Our Technology
  • Clinical
  • Investors
  • Careers

© 2021 Iovance Biotherapeutics, Inc All Rights Reserved.

  • Privacy Policy
  • Disclaimer
  • Sitemap